PHLDA2 and melanoma: These results indicated that the majority of melanoma cells in melanoma may be the target of AGRN, but C2 PHLDA2+ Melanoma cells and C4 PCLAF+ Melanoma cells subgroup had different targeting intensities (line width between cells) for AGRN.